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ABSTRACT
Objectives To develop and validate strategies, using new
ultrasound-based mathematical models, for the prediction
of high-risk endometrial cancer and compare them with
strategies using previously developed models or the use of
preoperative grading only.
Methods Women with endometrial cancer were prospec-
tively examined using two-dimensional (2D) and
three-dimensional (3D) gray-scale and color Doppler
ultrasound imaging. More than 25 ultrasound, demo-
graphic and histological variables were analyzed. Two
logistic regression models were developed: one ‘objective’
model using mainly objective variables; and one ‘subjec-
tive’ model including subjective variables (i.e. subjective
impression of myometrial and cervical invasion, preop-
erative grade and demographic variables). The following
strategies were validated: a one-step strategy using only
preoperative grading and two-step strategies using preop-
erative grading as the first step and one of the new models,
subjective assessment or previously developed models as
a second step.
Results One-hundred and twenty-five patients were
included in the development set and 211 were included
in the validation set. The ‘objective’ model retained
preoperative grade and minimal tumor-free myometrium
as variables. The ‘subjective’ model retained preoperative
grade and subjective assessment of myometrial invasion.
On external validation, the performance of the new
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models was similar to that on the development set.
Sensitivity for the two-step strategy with the ‘objective’
model was 78% (95% CI, 69–84%) at a cut-off of
0.50, 82% (95% CI, 74–88%) for the strategy with the
‘subjective’ model and 83% (95% CI, 75–88%) for that
with subjective assessment. Specificity was 68% (95% CI,
58–77%), 72% (95% CI, 62–80%) and 71% (95% CI,
61–79%) respectively. The two-step strategies detected
up to twice as many high-risk cases as preoperative
grading only. The new models had a significantly higher
sensitivity than did previously developed models, at the
same specificity.
Conclusion Two-step strategies with ‘new’ ultrasound-
based models predict high-risk endometrial cancers with
good accuracy and do this better than do previously
developed models. Copyright  2013 ISUOG. Published
by John Wiley & Sons Ltd.
INTRODUCTION
Endometrial cancer is the most common gynecologic
malignancy in developed countries, with an incidence
of 12.9 per 100 000 women and a mortality rate of
2.4 per 100 000 women1. Prognosis in the early stages
of the disease (Stage I–II) depends on age, histological
type and grading, depth of myometrial invasion, cervical
invasion and lymph-node metastases. Most women
with endometrial cancer are diagnosed at an early stage
when the prognosis is excellent2. However, women with
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high-risk endometrial cancer (high grade, deep myome-
trial invasion or cervical invasion) have a worse prognosis.
These women are at a higher risk of recurrence and might
benefit from extended surgical staging with systematic
pelvic and para-aortic lymphadenectomy in order to
tailor adjuvant therapy. On the other hand, it is important
to avoid overtreatment, as most of these women are
elderly with comorbidities. Lymphadenectomy shows no
survival benefit in low-risk endometrial cancer patients
and, in fact, results in increased complications and higher
morbidity3–7.
Thus far, preoperative risk stratification is mainly based
on the use of preoperative grading (classifying Grade
3 endometrioid and the non-endometrioid histological
subtypes (clear cell or serous carcinomas and carcinosar-
comas) as high risk) and computed tomography scans to
screen for enlarged lymph nodes. In most countries preop-
erative sonographic assessment of the uterus to evaluate
myometrial infiltration and cervical invasion is not yet
standard practice. However, several studies have assessed
subjective assessment of myometrial invasion using
transvaginal ultrasound, with sensitivities of 68–93% and
specificities of 82–83%8–11. There are fewer publications
on the use of ultrasound to assess cervical invasion, but
the results are generally very good8,10,12. The accuracy
of ultrasonography seems to be comparable with that of
magnetic resonance imaging (MRI)13–16. Nevertheless, at
present, MRI is less accessible because it is more expen-
sive and time consuming and, in most centers, the waiting
lists are quite long. Therefore, if access to MRI is lim-
ited, priority could be given to patients with poor image
quality during ultrasound as a result of obesity, fibroids,
adenomyosis or the anatomic position of the uterus.
Currently, most studies that use ultrasound to predict
high-risk endometrial cancer or deep myometrial invasion
are based on the performance of subjective assessment
or ultrasound parameters only. Our hypothesis was that
mathematical models combining ultrasound data with
other available preoperative information could improve
the ability to identify high-risk endometrial cancer.
The primary aim of this study was to assess whether
new mathematical models that include ultrasound, demo-
graphic variables and grade may improve the preoperative
identification of women with high-risk endometrial can-
cer. The secondary aim was to validate the new models
and compare them with previously published models17,18.
METHODS
This was a prospective international multicenter study
that included patients with endometrial cancer confirmed
histologically between January 2007 and May 2009.
The four centers that contributed to this study were the
gynecologic ultrasound unit at the Department of Obstet-
rics and Gynecology, Lund University Hospital, Sweden;
the Gynecologic Oncology Unit, Catholic University
of the Sacred Heart, Rome, Italy; the Department of
Obstetrics and Gynecology, Leuven University Hospitals,
Leuven, Belgium and the Department of Obstetrics
and Gynecology of Ziekenhuis Oost-Limburg, Genk,
Belgium; and the Gynecological Oncology Center and
Department of Obstetrics and Gynecology, Charles
University, Prague, Czech Republic. Ethical approval was
obtained from the Ethics Committee of Lund University
(LU-412-07) and from the local Ethics Committees of
the Catholic University of the Sacred Heart (Rome,
Italy), University Hospitals Leuven (Leuven, Belgium)
and Ziekenhuis Oost-Limburg (Genk, Belgium).
We included patients with a histologically proven diag-
nosis of endometrial cancer obtained by pipelle, dilata-
tion and curettage (D&C) or hysteroscopy. All patients
underwent a standardized ultrasound examination by an
experienced ultrasound examiner (C.V.H., E.E., A.C.T.
or D.F.) following a strict protocol. The two-dimensional
(2D) and three-dimensional (3D) gray-scale and vascular
pattern criteria were defined at a consensus reading session
including all examiners using the International Endome-
trial Tumor Analysis (IETA) terminology19. The objective
ultrasound variables that were assessed during real-time
2D examination included: tumor size in three perpendic-
ular diameters; minimal tumor-free margin (the minimal
thickness of the tumor-free myometrium, i.e. the area
at which the tumor is invading most (measured perpen-
dicular to the serosa)); the tumor/uterine anteroposterior
(AP) diameter ratio; tumor echogenicity; the endome-
trial/myometrial border (regular/irregular); the presence
and number of fibroids; the distance from the outer cervi-
cal os to the caudal border of the lesion; and vasculariza-
tion characteristics. The amount of tumor vascularization
was classified subjectively using a ‘color score’ (absent
(= 1), minimal (= 2), moderate (= 3) or high (= 4)), as
introduced by the International Ovarian Tumor Analysis
(IOTA) group20. From the stored 3D volumes we calcu-
lated the tumor volume, the uterine volume and the tumor
volume/uterine volume ratio, and we assessed vascular
morphology using GE 4D View (GE Healthcare, Little
Chalfont, UK) or Philips QLAB (Koninklijke Philips N.V.,
Amsterdam, The Netherlands), using 30◦ rotational steps.
The examiners also reported on their subjective assess-
ment of myometrial and cervical infiltration. Subjective
assessment is the personal impression of the ultrasound
examiner of depth of invasion and cervical invasion whilst
scanning the uterus. Patients were classified as high risk
when the ultrasound examiner believed that the tumor
invaded one half or more of the myometrium or when
cervical stromal invasion was suspected.
The ultrasound equipment used in Lund was a GE
Voluson E8 ultrasound system with a RIC5-9 transducer
or a Philips IU22 Ultrasound system with a 3D9-3v
transducer. In the hospitals in Rome, Leuven and Genk,
the GE Voluson E8 with a RIC5-9 transducer was used.
Static images with all measurements, videoclips with
and without power Doppler, and 3D volumes with and
without power Doppler were collected for every patient.
All women underwent an extrafascial abdominal
hysterectomy with bilateral salpingoophorectomy and
systematic pelvic and para-aortic lymphadenectomy,
if appropriate, according to the local protocols. The
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(FIGO) stage that was assigned to each case was
based on final histology. In each center, the surgical
specimens were examined by a dedicated pathologist
with substantial experience in gynecologic oncology
using a predetermined protocol. The histopathological
variables that were assessed were: histological subtype
(endometrioid/non-endometrioid; based on preoperative
biopsy and on hysterectomy); grade of differentiation
(based on preoperative biopsy and on hysterectomy);
tumor size, macroscopic growth pattern and macroscopic
estimation of infiltration; number of fibroids; microscopic
infiltration; minimal tumor-free myometrium; cervical
invasion; extension to parametria; and FIGO classifica-
tion. The tumors were classified according to the criteria
recommended by the World Health Association (WHO)
and the pathological tumor stage according to the
criteria recommended by the International Union Against
Cancer (TNM Classification of malignant tumors)21. The
FIGO 2009 staging criteria were used22. Only epithelial
malignant tumors and carcinosarcomas (malignant
mesodermal mixed tumors (MMMTs)) were included.
Endometrial adenocarcinoma was classified into three
grades (Grade 1, well differentiated; Grade 2, moderately
differentiated; and Grade 3, poorly differentiated). Other
histological subtypes, such as serous/seropapillary, clear
cell and carcinosarcoma, were classified as Grade 3. The
final allocation of high-risk status of a tumor was based
on the microscopic findings in the hysterectomy specimen
(i.e. Stage Ib or more, or Grade 3/non-endometrioid
histotype (serous, clear cell or carcinosarcoma)).
The prediction of high-risk cancer was performed using
either the preoperative grading only (i.e. the ‘one-step
strategy’) or a ‘two-step strategy’ (Figure 1). In the
first phase of the study, all patients with a poorly
differentiated carcinoma or a non-endometrioid cancer
(serous, clear cell or carcinosarcoma) on preoperative
biopsy were automatically classified as high-risk cancers.
For the remaining patients (Grade 1 and Grade 2) we
created mathematical models to predict high-risk cancer,
ultimately adding the results from both groups. In the
second phase we externally validated the new models used
in the two-step strategy and compared their performance
with previously published strategies.
The gold standard was the FIGO classification that
was assigned after final histopathological analysis of the
specimen.
For the development of a new two-step model we used
125 women examined in Lund, Leuven/Genk and Rome.
Among these, 94 had a Grade 1 or a Grade 2 tumor
based on preoperative histology. The external validation
was based on 211 new consecutive cases examined in
Prague that had not contributed to the development set;
163 of these cases had a Grade 3 tumor on preoperative
histology and were used for model validation.
We developed two new logistic regression models.
The ‘objective model’ considered all the variables listed
in the univariate analysis and subjective assessment of
cervical invasion as possible predictors. The ‘subjective
All patients
(n = 125)
Preoperative Grade 3
(n = 31)
(a)
(b)
High risk Low risk
High risk Low risk
Preoperative Grade 1 or 2
(n = 94)
All patients
(n = 125)
Preoperative Grade 3
(n = 31)
Preoperative Grade 1 or 2
(n = 94)
Models
Subjective impression
Figure 1 Flow charts for the prediction of high-risk endometrial
cancer using one-step (a) and two-step (b) strategies.
model’ considered subjective variables (i.e. subjective
impression of myometrial and cervical stromal invasion,
preoperative grading and all demographic variables) as
possible predictors.
Old models in the validation included:
• The Karlsson criteria. Karlsson defined the following
criteria to predict deep myometrial infiltration; the
maximal AP thickness of the endometrial lesion
measured in the sagittal plane (d1) divided by the
AP uterine diameter (d2) (Figure 2). More than 50%
myometrial infiltration was defined as d2/d1 ≥ 50%;
less than 50% myometrial infiltration was defined
as d2/d1 < 50%10. Cervical infiltration was suspected
when there was no clear demarcation of the endometrial
lesion toward the cervical canal17.
• The logistic regression model of De Smet et al.
This mathematical model was developed to predict
deep myometrial invasion (> 50% infiltration), and
variables selected included preoperative grade, number
of fibroids, endometrial thickness and endometrial
volume (calculated from three measurements of the
endometrium in two perpendicular planes)18.
Statistical analysis
All ultrasound and demographic variables were first
assessed in a univariate analysis. Differences between high
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Figure 2 Schematic representation, according to the criteria of Karlsson17, to demonstrate: (a) deep myometrial infiltration (d2/d1 ≥ 50%),
myometrial infiltration of less than 50% (d2/d1 < 50%) and (c) cervical infiltration.
risk and low risk in continuous variables were assessed
using a t-test and the Mann–Whitney U-test; differences
in categorical variables were assessed using the chi-square
test and Fisher’s exact test.
As described previously, we decided to create two new
mathematical models: one containing mainly objective
measurements, ‘the objective model’, and the other
also including subjective assessment of cervical and
myometrial invasion. By the use of stepwise logistic
regression we selected variables for the models. Only
variables with a univariate P < 0.2 were considered as
possible predictors in the multivariate model.
The different prediction strategies were tested at two
different cut-off levels: 0.40 and 0.50. The cut-off level
of 0.50 gave the best sensitivity for an acceptable level of
specificity. The cut-off level of 0.40 was tested to evaluate
the level of specificity when increasing sensitivity. The cut-
off levels represent values for the mathematical model and
are not related to absolute risk. To compare differences in
sensitivity and specificity between the different strategies,
the McNemar test was used. All statistical analyses were
performed with SAS 9.3 (SAS Institute Inc., Cary, NC,
USA). All P-values were two-sided and P < 0.05 was
considered significant.
RESULTS
Of the 144 patients initially included in this study, 19
were excluded because no information on preoperative
grade was available. The demographic and clinical
characteristics for women with high- and low-risk cancer
from development and validation sets, according to final
histology, are presented in Table 1. Women with high-risk
cancer were significantly older than were women with
low-risk cancer.
The preoperative histology, final histology and final
staging of development and validation sets are presented
in Table 2. Around half of the tumors were Stage IA, in
both development and validation sets. On the preoperative
biopsy, 25% of cases in both development and validation
sets had a high-grade tumor. The ultrasound examiner
assumed that there was cervical invasion in 17% (21/125)
of cases and deep myometrial invasion in 41% (51/125).
Table S1 shows the univariate analysis of the 2D and
3D gray-scale and color Doppler ultrasound variables
for the women with Grades 1 and 2 endometrial cancer
according to preoperative biopsy included in the develop-
ment set (n = 94). The retained variables for the objective
model were preoperative grade and minimal tumor-free
myometrium. The subjective model used subjective
assessment of myometrial invasion, preoperative grade
and age as variables.
The probability of having high-risk cancer is equal to
y1/(1 + e–z), where z is −0.4468 + 1.2921 × preoperative
grading –0.2292 × minimal-free myometrium (for the
objective model) and −2.6276 + 1.1458 × preoperative
grading + 2.2514 × subjective evaluation of myometrial
invasion (for the subjective model).
Table 3 shows the results for predicting high-risk
cancer for: a one-step strategy using Grade 3 only; the
combined two-step strategies as described above; and the
performance of the new ultrasound-based mathematical
models and subjective assessment alone (when tested only
on the preoperative Grade 1 and 2 patients). Of the 31
women classified as high risk according to preoperative
grading, one woman was later found to be low risk
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Table 1 Demographic and baseline characteristics of patients included in the total development set (n = 125 = 94 + 31) and the total
validation set (n = 211 = 163 + 48) stratified by ‘low-risk’ and ‘high-risk’ cancer according to final pathology
Development set Validation set
Characteristic
Total
(n = 125)
Low risk
(n = 55)
High risk
(n = 70) P
Total
(n = 211)
Low risk
(n = 90)
High risk
(n = 121) P
Age (years) 66 ± 10 63 ± 9 68 ± 10 0.006 65 ± 9 62 ± 9 66 ± 9 < 0.001
66 (37–92) 64 (37–82) 67 (44–92) 64 (41–89) 61 (41–81) 66 (44–89)
BMI* 29 ± 7 29 ± 6 29 ± 7 0.89 31 ± 8 32 ± 8 31 ± 7 0.34
27 (19–55) 27 (19–46) 27 (20–55) 30 (18–61) 30 (18–55) 30 (20–61)
Postmenopausal
No 8 (6) 3 (5) 5 (7) 1 17 (8) 12 (13) 5 (4) 0.02
Yes 117 (94) 52 (95) 65 (93) 194 (92) 78 (87) 116 (96)
Hormone treatment
No 112 (90) 48 (87) 64 (91) 0.56 199 (94) 83 (92) 116 (96) 0.37
Yes 13 (10) 7 (13) 6 (9) 12 (6) 7 (8) 5 (4)
Current low-potency
estrogen use
No 112 (90) 47 (85) 65 (93) 0.24 210 (99.5) 89 (99) 121 (100) —
Yes 13 (10) 8 (15) 5 (7) 1 (0.5) 1 (1) —
Current tamoxifen use
No 122 (98) 52 (95) 70 (100) 0.08 209 (99) 90 (100) 119 (98) —
Yes 3 (2) 3 (5) — 2 (1) — 2 (2)
Family history
Breast cancer
No 106 (85) 47 (85) 59 (84) 1 200 (95) 86 (96) 114 (94) 0.76
Yes 19 (15) 8 (15) 11 (16) 11 (5) 4 (4) 7 (6)
Gynecological cancer
No 107 (86) 45 (82) 62 (89) 0.31 198 (94) 80 (89) 118 (98) 0.02
Yes 18 (14) 10 (18) 8 (11) 13 (6) 10 (11) 3 (2)
Diagnosis by:
Pipelle biopsy 21 (19) 12 (27) 9 (14) 0.14 — — — 0.58
Hysteroscopy only 19 (17) 4 (9) 15 (23) 93 (46) 42 (48) 51 (44)
D&C only 52 (48) 22 (49) 30 (47) 82 (40) 36 (41) 46 (40)
Hysteroscopy and D&C 17 (16) 7 (16) 10 (16) 29 (14) 10 (11) 19 (16)
No data/not performed/
other method (tru-cut
biopsy/biopsy of meta)
16 10 6 7 2 5
Values are given as n, n (%), mean ± SD or median (range). *Data for BMI missing in three low-risk and 12 high-risk cases in the
development set. BMI, body mass index; D&C, dilatation and curettage.
according to final histology. Subjective assessment alone
performed as well as any model. A two-step strategy with
the ‘subjective’ or ‘objective’ model as the second step
achieved a significantly higher sensitivity in comparison
with preoperative grading only. All two-step strategies
using models had similar specificities, indicating that
ultrasound in the combination with grade will improve
the correct identification of high-risk cases. The two-step
strategies detected up to twice as many high-risk cases as
did the one-step strategy based on grade only. Differences
when using different cut-offs are explained below.
In Tables S2 and S3 we compared the P-values for the
difference in sensitivity and specificity between the two-
step strategy using models or subjective assessment, and
between the use of different cut-offs in the development
set. The only difference between the models and subjective
assessment using the 0.5 cut-off was a significantly lower
specificity for the objective model (P = 0.03), and when
using the 0.4 cut-off both objective and subjective models
had a lower specificity (both P < 0.001), the subjective
model having a higher sensitivity (P = 0.03) compared
with subjective assessment. Thus, the 0.5 cut-off achieved
a result more similar to subjective assessment, but the use
of a 0.4 cut-off detected more high-risk cases at a cost of
lower specificity.
Table 4 shows the external validation of preoperative
grading only and the two-step strategies with our ‘new’
models, subjective assessment or previously published
models (of Karlsson and coworkers and De Smet and co-
workers) as the second step. As in Table 3 the performance
is presented for the models individually or for the whole
two-step strategy. Of the 48 women classified as high risk
according to preoperative grading, four were later found
to be low risk according to final histology. The ultrasound
examiner assumed that there was cervical invasion in
11% (24/211) cases and deep myometrial invasion in
52% (109/211). The performance of the models in the
validation set was very similar to the results from the
development set.
Tables S4 and S5 compare the P-values for the
differences in sensitivity and specificity between two-step
strategies using new and old models as the second step
and subjective assessment using different cut-off levels
and subjective assessment for the validation set. The
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Table 2 Histological characteristics of patients included in the total development set (n = 125 = 94 + 31) and the validation set (n =
211 = 163 + 48)
Development set Validation set
Total Grade 3 Grade 1 or 2 Total Grade 3 Grade 1 or 2
Characteristic (n = 125) (n = 40) (n = 85) (n = 211) (n = 51) (n = 160)
Stage, FIGO 200922
IA 64 (51) 11 (27.5) 53 (62) 106 (50) 17 (33) 89 (56)
IB 28 (22) 9 (22.5) 19 (22) 58 (27) 10 (20) 48 (30)
II 11 (9) 4 (10.0) 7 (8) 19 (9) 9 (18) 10 (6)
IIIA 3 (2) 3 (7.5) — 6 (3) 3 (6) 3 (2)
IIIB 2 (2) 1 (2.5) 1 (1) 1 (<1) 1 (2) —
IIIC 11 (9) 6 (15.0) 5 (6) 16 (8) 7 (14) 9 (6)
IVA — — — — — —
IVB 6 (5) 6 (15.0) — 5 (2) 4 (8) 1 (<1)
Development set (n = 125) Validation set (n = 211)
Type and grade preoperatively
Endometrioid
Grade 1 65 (52) 89 (42)
Grade 2 29 (23) 74 (35)
Grade 3 20 (16) 31 (15)
Non-endometrioid 11 (9) 17 (8)
Type and grade postoperatively
Endometrioid
Grade 1 51 (41) 100 (47)
Grade 2 34 (27) 60 (28)
Grade 3 19 (15) 35 (16)
Non-endometrioid 21 (17)* 16 (8)†
Values are given as n (%). *Non-endometrioid histotypes, after final surgery, in the development set (four carcinosarcoma, three clear cell,
three mixed, three seropapillary and eight serous). †Non-endometrioid histotypes, after final surgery, in the validation set (four clear cell,
two mixed, seven serous, two undifferentiated, one squamous).
sensitivity for any of the new models and for subjective
assessment performed significantly better compared with
the old models at the same level of specificity.
In Figure 3a and b, pie charts present and compare the
performance of all strategies on the development and the
validation set.
Figure 4 shows the percentage of additional women
with a correct diagnosis compared with the one-step strat-
egy using preoperative Grade 3 only in the validation set.
The subjective models and subjective assessment improved
the accuracy by 16%. In the development set the accuracy
was improved by up to 29% (for subjective assessment
and the subjective model (at the cut-off of 0.5)).
DISCUSSION
Good preoperative risk stratification is of utmost impor-
tance. Surgical staging to identify high-risk cancers and
to decide whether to proceed with a lymphadenectomy is
based on several factors: histological tumor type; grade of
tumor differentiation; depth of myometrial invasion; and
cervical extension. The first two factors can be determined
on the preoperative endometrial biopsy, although the
tumor grade might have been underestimated as becomes
clear on the final microscopic analysis of the hysterec-
tomy specimen. However, depth of myometrial invasion
and cervical extension to a certain extent can only be
assessed during surgery and therefore are not available to
guide appropriate referral23.
In this study we prospectively developed and tested new
mathematical models aiming to preoperatively identify
women with high-risk endometrial cancer. We found that
a two-step strategy combining Grade 3 with either one
of the models as a second step or subjective assessment
detected up to almost twice as many high-risk cases as
preoperative grade alone (78–83% for two-step strategies
vs 36% for preoperative grade alone) at the comparable
level of specificity (68% for the objective model, 72% for
the subjective model and 71% for subjective assessment)
vs 96% (validation set, cut-off level = 0.50 for both
models). Subjective assessment performed as well as any
of the models. Based on the preoperative grading, 75% or
77% (development and validation sets, respectively) of the
women were considered as low risk. Among these low-risk
patients, 42% (40/94) and 47% (77/163) were classified as
high risk according to the final surgical staging, indicating
a need for repeat surgery with lymphadenectomy or
complementary treatment with radiochemotherapy. By
introducing the two-step strategy one could improve
the correct classification of the patients by up to 16%
(Figure 4). Looking at the whole group, preoperative
grading only would miss 64% of the high-risk patients,
the models would miss 17–22% of the high-risk patients
and subjective assessment would miss 17%.
We tested two different cut-off levels for the models to
determine which would yield the most favorable clinical
outcome in terms of trade-off between sensitivity and
specificity. The 0.5 cut-off gave results that were very
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Table 3 Ability of the two-step strategy to detect high-risk endometrial cancer through combining preoperative Grade 3 with
ultrasound-based mathematical models or subjective assessment in the development set (n = 125)
Preoperative Grade 3 (n = 31) Model
Preoperative
Grade 1 or 2 (n = 94) Total (n = 125)
PPV = 30/31 Objective model
AUC 0.76 (0.66–0.86)
Cut-off 0.5
Sensitivity (%) 63 (46–77) [25/40] 79 (68–87) [55/70]
Specificity (%) 74 (60–85) [40/54] 73 (60–83) [40/55]
LR+ 2.41 (1.45–4.02) 2.88 (1.84–4.51)
LR– 0.51 (0.33–0.78) 0.30 (0.18–0.48)
Cut-off 0.4
Sensitivity (%) 70 (53–83) [28/40] 83 (72–90) [58/70]
Specificity (%) 61 (47–74) [33/54] 60 (47–72) [33/55]
LR+ 1.80 (1.22–2.66) 2.07 (1.47–2.91)
LR– 0.49 (0.29–0.83) 0.29 (0.16–0.50)
Subjective model
AUC 0.78 (0.68–0.87)
Cut-off 0.5
Sensitivity (%) 63 (46–77) [25/40] 79 (68–87) [55/70]
Specificity (%) 85 (73–83) [46/54] 84 (72–91) [46/55]
LR+ 4.22 (2.13–8.35) 4.80 (2.61–8.84)
LR– 0.44 (0.29–0.67) 0.26 (0.16–0.41)
Cut-off 0.4
Sensitivity (%) 75 (59–87) [30/40] 86 (76–92) [60/70]
Specificity (%) 65 (51–77) [35/54] 64 (50–75) [35/55]
LR+ 2.13 (1.42–3.19) 2.36 (1.64–3.39)
LR– 0.39 (0.22–0.68) 0.22 (0.12–0.41)
Subjective impression
Sensitivity (%) 63 (46–77) [25/40] 79 (68–87) [55/70]
Specificity (%) 85 (73–93) [46/54] 84 (72–91) [46/55]
LR+ 4.22 (2.13–8.35) 4.80 (2.61–8.84)
LR– 0.44 (0.29–0.67) 0.26 (0.16–0.41)
All low risk
Sensitivity (%) 0 (0–9) [0/40] 43 (32–55) [30/70]
Specificity (%) 100 (93–100) [54/54] 98 (90–100) [54/55]
LR+ 23.57 (3.32–167.48)
LR– 0.58 (0.47–0.72)
Values in round parentheses are 95% CI and those in square parentheses are n/n. AUC, area under the curve; LR+, positive likelihood ratio;
LR–, negative likelihood ratio; PPV, positive predictive value.
close to that of subjective impression in both development
and validation sets. There seems to be no benefit in use of
the 0.4 cut-off.
The variables selected by the objective model were
preoperative grade (Grade 1 or 2) and minimal tumor-
free myometrium, which are not directly related to the
subjective assessment of the examiner.
In the past, several attempts have been made to
improve the current preoperative risk stratification. The
aim of Karlsson’s criteria was to predict deep myometrial
infiltration, not high-risk cancer patients. Using his
criteria, as described above, he achieved a sensitivity of
79% and a specificity of 100%17. Because Karlsson also
described cervical invasion as one of the criteria, we could
assess Karlsson’s criteria as a two-step strategy also for
the prediction of high-risk cancers. Alcazar et al. assessed
myometrial infiltration by assessing stored 3D volumes. In
each plane the minimal tumor-free myometrial thickness
was measured. The study showed that the best cut-off
to predict more than 50% myometrial infiltration was a
minimal tumor-free myometrial margin of 9 mm, resulting
in a sensitivity of 100% and a specificity of 61%24. De
Smet et al. developed a logistic regression model with
degree of differentiation, number of fibroids, endometrial
thickness and tumor volume as variables. He achieved,
after validation, a sensitivity of 50% to predict deep
infiltration and a specificity of 75%18.
We compared our new models with those previously
developed models (Karlsson and De Smet) and found
that the new models performed significantly better, the
sensitivity being significantly better for the new model
at the same level of specificity. Nevertheless, there is
still room for improvement of the performance of our
models because we did not achieve optimal results
for sensitivity and specificity. Perhaps new biochemical
tumor markers, new histological tumor markers or new
ultrasound techniques can improve this performance, but
we conclude that, at present, the current 3D ultrasound
variables are not able to improve performance and 2D
ultrasound assessment is sufficient at this stage.
Because De Smet et al. did not assess cervical invasion,
which inevitably upgrades the stage to Stage II, the
Copyright  2013 ISUOG. Published by John Wiley & Sons Ltd. Ultrasound Obstet Gynecol 2014; 43: 586–595.
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Table 4 External validation of the new and previously developed models and subjective assessment (validation set, n = 211)
Preoperative
Grade 3 (n = 48) Model
Preoperative
Grade 1 or 2 (n = 163) Total (n = 211)
PPV = 44/48 Objective model
AUC 0.73 (0.66–0.81)
Cut-off 0.5
Sensitivity (%) 65 (53–75) [50/77] 78 (69–84) [94/121]
Specificity (%) 71 (60–80) [61/86] 68 (58–77) [61/90]
LR+ 2.23 (1.55–3.23) 2.41 (1.76–3.30)
LR– 0.49 (0.35–0.69) 0.33 (0.23–0.47)
Cut-off 0.40
Sensitivity (%) 73 (61–82) [56/77] 83 (75–88) [100/121]
Specificity (%) 58 (47–69) [50/86] 56 (45–65) [50/90]
LR+ 1.74 (1.31–2.31) 1.86 (1.46–2.38)
LR– 0.47 (0.31–0.70) 0.31 (0.20–0.48)
Subjective model
AUC 0.77 (0.70–0.85)
Cut-off 0.5
Sensitivity (%) 71 (60–81) [55/77] 82 (74–88) [99/121]
Specificity (%) 76 (65–84) [65/86] 72 (62–80) [65/90]
LR+ 2.93 (1.97–4.35) 2.95 (2.09–4.15)
LR– 0.38 (0.26–0.55) 0.25 (0.17–0.38)
Cut-off 0.4
Sensitivity (%) 71 (60–81) [55/77] 82 (74–88) [99/121]
Specificity (%) 76 (65–84) [65/86] 72 (62–80) [65/90]
LR+ 2.93 (1.97–4.35) 2.95 (2.09–4.15)
LR– 0.38 (0.26–0.55) 0.25 (0.17–0.38)
Subjective assessment
Sensitivity (%) 73 (62–81) [56/77] 83 (75–88) [100/121]
Specificity (%) 74 (64–83) [64/86] 71 (61–79) [64/90]
LR+ 2.84 (1.93–4.18) 2.86 (2.05–4.00)
LR– 0.37 (0.25–0.54) 0.24 (0.16–0.37)
De Smet
Sensitivity (%) 51 (40–62) [39/77] 69 (60–76) [83/121]
Specificity (%) 79 (69–87) [68/86] 76 (66–83) [68/90]
LR+ 2.42 (1.52–3.86) 2.81 (1.91–4.12)
LR– 0.62 (0.49–0.80) 0.42 (0.31–0.56)
Karlsson
Sensitivity (%) 47 (42–65) [36/77] 66 (57–74) [80/121]
Specificity (%) 78 (68–86) [67/86] 74 (65–82) [67/90]
LR+ 2.12 (1.33–3.36) 2.59 (1.78–3.76)
LR– 0.68 (0.54–0.87) 0.46 (0.35–0.60)
All low risk
Sensitivity (%) 0 (0–5) [0/77] 36 (28–45) [44/121]
Specificity (%) 100 (96–100) [86/86] 96 (89–98) [86/90]
LR+ 8.18 (3.05–21.94)
LR– 0.67 (0.58–0.77)
Values in round parentheses are 95% CI and those in square parentheses are n/n. AUC, area under the curve; LR+, positive likelihood ratio;
LR–, negative likelihood ratio; PPV, positive predictive value.
comparison between the two-step strategy using De
Smet’s model as the second step and the other two-step
strategies is not completely fair and the two-step strategy
with De Smet’s model might be performing less well,
for this reason. Another weakness in this study is that
a lymphadenectomy was not performed in all patients
because patients were treated according to local protocols
and, in several centers, patients with low-risk cancer do
not undergo a lymphadenectomy. Nevertheless, the new
FIGO staging requires lymphadenectomy and therefore
the staging of the patients might be underestimated.
In several centers MRI is the standard preoperative
imaging for risk stratification, but this is certainly not the
case in all countries; therefore, we decided to develop and
evaluate strategies with ultrasound-based models rather
than with MRI, although a comparison with MRI would
have been interesting.
It remains to be shown whether a two-step strategy
containing subjective ultrasound assessment or objective
ultrasound measurements will have the highest repro-
ducibility and if any of the strategies work as well in the
hands of less-experienced examiners.
The issues that need to be considered when we
compare the debate of the preoperative prediction of
malignancy in adnexal masses with that of the prediction
of high-risk endometrial cancers, are completely different.
Copyright  2013 ISUOG. Published by John Wiley & Sons Ltd. Ultrasound Obstet Gynecol 2014; 43: 586–595.
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Figure 3 Pie charts demonstrating performance of one-step and
two-step strategies on the development set (n = 125) (a) and on the
whole validation set (n = 211) (b). , true positive; , false positive;
, true negative; , false negative.
The main reason is that there is no general international
consensus on the treatment strategy of patients with
endometrial cancers, more specifically on which patients
should be treated with a lymphadenectomy and which
patients should receive adjuvant radiotherapy. Therefore,
depending on the clinical setting of the local hospital and
the local protocol that is followed, the cut-off that is used
by the model could be changed. Hospitals that offer easy
access to a team with special skills in lymphadenectomy
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Figure 4 Percentage improvement, using validation set (n = 211), in
preoperative classification of endometrial cancers using
ultrasound-based models (objective (Obj.) and subjective (Subj.)
models with two different cut-offs, subjective impression, and the
older models of De Smet and Karlsson), compared with
preoperative grading only.
could opt for the cut-off that gives the highest sensitivity
for an acceptable false-positive rate, thus reducing the
number of patients who undergo unnecessary radiother-
apy. On the other hand, patients with endometrial cancer
are quite often obese with a substantial degree of comor-
bidity, making lymphadenectomy a technically difficult
procedure with substantial risks of complications.
In conclusion, based on this study we have shown that
a two-step strategy combining preoperative grade and
ultrasound-based mathematical models can help us iden-
tify twice as many women with high-risk cancer compared
with a strategy based on preoperative grade alone, and can
improve the correct classification of patients by 29%. Fur-
ther research is needed to evaluate whether referral based
on this adapted strategy will improve patient outcome.
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SUPPORTING INFORMATION ON THE INTERNET
The following supporting information may be found in the online version of this article:
Table S1 Univariate analysis of the two-dimensional (2D) and three-dimensional (3D) gray-scale and color
Doppler ultrasound variables of the endometrial cancers included in the model building dataset (n = 94)
Tables S2 and S3 Difference in sensitivity (Table S2) and specificity (Table S3) between two-step strategies
using models as the second step and subjective assessment, and according to different cut-offs (values are
given as P) (development set, n = 125)
Tables S4 and S5 Difference in sensitivity (Table S4) and specificity (Table S5) between two-step strategies
using models as the second step and subjective assessment, and according to different cut-offs (values are
given as P) (validation set, n = 211)
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